Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,907,194
-
Share change
-
+4,906,194
-
Total reported value
-
$56,957,000
-
Put/Call ratio
-
57%
-
Price per share
-
$11.61
-
Number of holders
-
31
-
Value change
-
+$56,946,000
-
Number of buys
-
30
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2021
As of 30 Sep 2021,
Humacyte, Inc. - COM (HUMA) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,907,194 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Diameter Capital Partners LP, Monashee Investment Management LLC, CVI Holdings, LLC, Maven Securities LTD, VANGUARD GROUP INC, LPL Financial LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, and Eudaimonia Partners, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.